SEC Form 4 · accession 0001587221-17-000014
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Peter Walker
Officer — Interim CEO · Director
Period of report
May 18, 2017
Accepted (ET)
May 22, 2017 · 6:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 18, 2017 | A | 60,000 | $0.00 | A | 133,178 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The common stock is subject to vesting as follows: 10,000 shares shall vest on May 31, 2017, and an additional 10,000 shares shall vest at the end of each month thereafter, such that all of the shares shall be vested on October 31, 2017.